Parkinson’s researchers receive nearly $3 million in grant funding
The US Parkinson’s Foundation has invested nearly $3 million for 33 grants to accelerate Parkinson’s disease (PD) research.
The research grants will fund scientists conducting studies across various aspects of PD to bring forward new therapies, treatments, and ultimately a cure for the disease.
“We are excited to fund these promising grant recipients as they develop more effective pathways for potential treatments and improved models for patient care to help provide a better quality of life for people living with PD,” said James Beck, Chief Scientific Officer of the Parkinson’s Foundation.
Rebecca Wallings, the recipient of the Parkinson’s Foundation Launch Award, from the Center of Translational Research and Neurodegenerative Disease (CTRND) at the University of Florida, will expand on her most recent findings in neuroimmunological advances in PD research.
The grant will allow her to further explore the novel role of immune cell exhaustion in PD and better understand how immune cell exhaustion in peripheral immune cells can lead to neurodegeneration in the brain. The study’s findings, implicating PD mutations, could be targeted for potential therapeutics.
“My research is at the forefront of a potential paradigm shift in the neurodegeneration field and may change the way researchers think about the role of the immune system in PD,” said Wallings. “With this award, the Parkinson’s Foundation shows their willingness to invest in me and my research, and that they believe in my abilities and the potential impact my research may have on the field and, most importantly, on patients’ lives.”
Parkinson’s Foundation grants are selected through a highly competitive application process that is comprised of a peer-review panel of scientific experts, including members of the Foundation’s Scientific Advisory Board and Foundation-trained research advocates.
See a complete list of 2024 recipients.
Diana Spencer, Senior Digital Content Editor, DDW
